South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

sanofi-aventis south africa (pty) ltd - tablet - each tablet contains nicotinic acid 100 mg pentifylline 400 mg

Ireland - English - HPRA (Health Products Regulatory Authority)

essential pharma limited - lithium carbonate - prolonged-release tablet - 200 milligram(s) - lithium; lithium

Ireland - English - HPRA (Health Products Regulatory Authority)

essential pharma limited - lithium carbonate - prolonged-release tablet - 400 milligram(s) - lithium; lithium

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tramadol hydrochloride, quantity: 200 mg - tablet, modified release - excipient ingredients: hypromellose; hydrogenated castor oil; maize starch; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; lactose monohydrate; colloidal anhydrous silica; povidone; magnesium stearate; sodium starch glycollate; colour - tramadol sandoz sr is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long term treatment. tramadol sandoz sr is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. tramadol sandoz sr is not indicated as an as-needed (prn) analgesia.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tramadol hydrochloride, quantity: 150 mg - tablet, modified release - excipient ingredients: sodium starch glycollate; lactose monohydrate; colloidal anhydrous silica; maize starch; hypromellose; microcrystalline cellulose; magnesium stearate; povidone; calcium hydrogen phosphate dihydrate; hydrogenated castor oil; colour - tramadol sandoz sr is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long term treatment. tramadol sandoz sr is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. tramadol sandoz sr is not indicated as an as-needed (prn) analgesia.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tramadol hydrochloride, quantity: 100 mg - tablet, modified release - excipient ingredients: hypromellose; lactose monohydrate; calcium hydrogen phosphate dihydrate; magnesium stearate; sodium starch glycollate; hydrogenated castor oil; povidone; microcrystalline cellulose; maize starch; colloidal anhydrous silica; colour - tramadol sandoz sr is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long term treatment. tramadol sandoz sr is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. tramadol sandoz sr is not indicated as an as-needed (prn) analgesia.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - tramadol hydrochloride, quantity: 50 mg - tablet, modified release - excipient ingredients: purified talc; lactose monohydrate; hypromellose; titanium dioxide; propylene glycol; magnesium stearate; macrogol 6000; colloidal anhydrous silica; iron oxide yellow; microcrystalline cellulose - tramal sr is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long term treatment. tramal sr is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. tramal sr is not indicated as an as-needed (prn) analgesia.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - tramadol hydrochloride, quantity: 200 mg - tablet, modified release - excipient ingredients: magnesium stearate; macrogol 6000; titanium dioxide; hypromellose; colloidal anhydrous silica; microcrystalline cellulose; lactose monohydrate; propylene glycol; iron oxide red; iron oxide black; purified talc; quinoline yellow aluminium lake; iron oxide yellow - tramal sr is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long term treatment. tramal sr is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. tramal sr is not indicated as an as-needed (prn) analgesia.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - tramadol hydrochloride, quantity: 150 mg - tablet, modified release - excipient ingredients: hypromellose; quinoline yellow aluminium lake; microcrystalline cellulose; purified talc; lactose monohydrate; magnesium stearate; propylene glycol; iron oxide red; colloidal anhydrous silica; macrogol 6000; titanium dioxide - tramal sr is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long term treatment. tramal sr is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. tramal sr is not indicated as an as-needed (prn) analgesia.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - tramadol hydrochloride, quantity: 100 mg - tablet, modified release - excipient ingredients: hypromellose; lactose monohydrate; colloidal anhydrous silica; macrogol 6000; magnesium stearate; purified talc; titanium dioxide; microcrystalline cellulose; propylene glycol - tramal sr is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long term treatment. tramal sr is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. tramal sr is not indicated as an as-needed (prn) analgesia.